Northwest & Ethical Investments’s West Pharmaceutical WST Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.18M	Sell	4,706 -5,022	-52%	-$1.25M	0.03%	295
2025 Q4	$2.68M	Buy	9,728 +334	+4%	+$91.4K	0.06%	236
2025 Q3	$2.46M	Hold	9,394	–	–	0.06%	241
2025 Q2	$2.06M	Buy	+9,394	New	+$2.01M	0.05%	251
2022 Q4	–	Sell	-2,367	Closed	-$582K	–	430
2022 Q3	$582K	Sell	2,367 -64	-3%	-$19.5K	0.02%	341
2022 Q2	$735K	Buy	2,431 +447	+23%	+$145K	0.03%	327
2022 Q1	$815K	Sell	1,984 -491	-20%	-$192K	0.03%	317
2021 Q4	$1.16M	Buy	2,475 +638	+35%	+$275K	0.03%	286
2021 Q3	$780K	Buy	+1,837	New	+$774K	0.03%	316
2021 Q1	–	Sell	-8,847	Closed	-$2.51M	–	436
2020 Q4	$2.51M	Hold	8,847	–	–	0.1%	223
2020 Q3	$2.43M	Buy	8,847 +2,767	+46%	+$732K	0.11%	219
2020 Q2	$1.38M	Buy	+6,080	New	+$1.19M	0.07%	276